Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer
Omar Elakad(University of Göttingen), Hanibal Bohnenberger(Universitätsmedizin Göttingen)
Cited by 20
Related Papers
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
|Nature Medicine|2016|185
Deubiquitinase USP5 promotes non-small cell lung cancer cell proliferation by stabilizing cyclin D1
|Translational Lung Cancer Research|2021|57